암젠 주식회사
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionLincoln Capital Corp
Latest Disclosed Ownership1,943 shares
Latest Disclosed Value $ 683,558
Lincoln Capital Corp reports 13.06% decrease in ownership of AMGN / Amgen Inc.

On April 16, 2026 - Lincoln Capital Corp filed a 13F-HR form disclosing ownership of 1,943 shares of Amgen Inc. (MX:AMGN) valued at $683,558 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 2,235 shares of Amgen Inc.. This represents a change in shares of -13.06% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F AMGEN COM 031162100 1,943 -292 -13.06 684 -6.57 0.2516
2026-01-23 2025-12-31 13F AMGEN COM 031162100 2,235 0 0.00 731 16.03 0.2598
2025-10-16 2025-09-30 13F AMGEN COM 031162100 2,235 508 29.42 631 30.71 0.2268
2025-07-09 2025-06-30 13F AMGEN COM 031162100 1,727 453 35.56 482 21.72 0.1852
2025-04-28 2025-03-31 13F AMGEN COM 031162100 1,274 -439 -25.63 397 -11.21 0.1653
2025-01-21 2024-12-31 13F AMGEN COM 031162100 1,713 80 4.90 447 -15.21 0.1833
2024-10-23 2024-09-30 13F AMGEN COM 031162100 1,633 -310 -15.95 526 -13.34 0.2149
2024-07-24 2024-06-30 13F AMGEN COM 031162100 1,943 195 11.16 607 22.38 0.2600
2024-04-16 2024-03-31 13F AMGEN COM 031162100 1,748 0 0.00 497 -1.39 0.2174
2024-01-18 2023-12-31 13F AMGEN COM 031162100 1,748 0 0.00 503 7.25 0.2458
2023-11-03 2023-09-30 13F AMGEN COM 031162100 1,748 -270 -13.38 470 4.69 0.2530
2023-07-27 2023-06-30 13F AMGEN COM 031162100 2,018 0 0.00 448 -8.01 0.2296
2023-04-21 2023-03-31 13F AMGEN COM 031162100 2,018 100 5.21 488 -3.18 0.2830
2023-01-20 2022-12-31 13F AMGEN COM 031162100 1,918 0 0.00 504 16.44 0.3082
2022-10-24 2022-09-30 13F AMGEN COM 031162100 1,918 0 0.00 432 -7.49 0.2900
2022-07-22 2022-06-30 13F AMGEN COM 031162100 1,918 165 9.41 467 10.14 0.3012
2022-04-19 2022-03-31 13F AMGEN COM 031162100 1,753 -833 -32.21 424 -27.15 0.2212
2022-01-24 2021-12-31 13F AMGEN COM 031162100 2,586 -663 -20.41 582 -15.77 0.2798
2021-10-18 2021-09-30 13F AMGEN COM 031162100 3,249 -14,993 -82.19 691 -84.46 0.3711
2021-07-22 2021-06-30 13F AMGEN COM 031162100 18,242 -454 -2.43 4,447 -4.41 2.5366
2021-04-20 2021-03-31 13F AMGEN COM 031162100 18,696 -3,631 -16.26 4,652 -9.37 2.9019
2021-02-05 2020-12-31 13F AMGEN COM 031162100 22,327 -647 -2.82 5,133 -12.09 3.3674
2020-11-04 2020-09-30 13F AMGEN COM 031162100 22,974 -278 -1.20 5,839 6.47 4.2717
2020-07-22 2020-06-30 13F AMGEN COM 031162100 23,252 347 1.51 5,484 18.09 4.2911
2020-04-16 2020-03-31 13F AMGEN COM 031162100 22,905 996 4.55 4,644 -12.08 2.0804
2020-01-17 2019-12-31 13F AMGEN COM 031162100 21,909 -339 -1.52 5,282 22.69 3.9151
2019-11-05 2019-09-30 13F AMGEN COM 031162100 22,248 765 3.56 4,305 8.74 3.6400
2019-07-12 2019-06-30 13F AMGEN COM 031162100 21,483 58 0.27 3,959 -2.73 3.4861
2019-04-11 2019-03-31 13F AMGEN COM 031162100 21,425 131 0.62 4,070 -1.81 3.6824
2019-01-22 2018-12-31 13F AMGEN COM 031162100 21,294 -596 -2.72 4,145 -8.66 3.8224
2018-10-10 2018-09-30 13F AMGEN COM 031162100 21,890 6,478 42.03 4,538 59.51 3.7688
2018-07-26 2018-06-30 13F AMGEN COM 031162100 15,412 -7,037 -31.35 2,845 -25.66 2.6398
2018-04-12 2018-03-31 13F AMGEN COM 031162100 22,449 4,605 25.81 3,827 23.33 3.5561
2018-02-06 2017-12-31 13F AMGEN COM 031162100 17,844 -636 -3.44 3,103 -9.95 2.6486
2017-10-18 2017-09-30 13F AMGEN COM 031162100 18,480 664 3.73 3,446 12.32 3.0798
2017-07-25 2017-06-30 13F AMGEN COM 031162100 17,816 -25 -0.14 3,068 4.82 2.7131
2017-05-10 2017-03-31 13F AMGEN COM 031162100 17,841 1,464 8.94 2,927 22.06 2.6149
2017-03-24 2016-12-31 13F AMGEN COM 031162100 16,377 16,377 2,398 2.3092
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.